Dr. Jonathan Gruber: Can we control costs in healthcare reform?

Harvard Law School

Harvard Law School rounded up a panel of experts to discuss some of the implications of healthcare reform in the 1st annual Health Law in Review panel discussion.

Jonathan Gruber, an MIT economist and a healthcare reform advisor to President Barack Obama, said that many of the cost control measure the Patient Protection & Affordable Care Act encourages, such as involving consumers in insurance price-point shopping or promoting provider reimbursement based on health behavior of the enrollees, come with "thorny legal issues."

"It’s important to be realistic about the fact that implementing this is not going to be easy," Gruber said. "It’s going to be a mess."

Sign up to get our free newsletters delivered straight to your inbox

"Social equilibrium" is going to be the most difficult hurdle – running a nationwide campaign, similar to what was seen in 2006 in Massachusetts, to make the individual mandate a widely accepted notion, Gruber said.

Einer Elhauge, Harvard Law School professor and former chairman of the president’s Antitrust Advisory Committee, also spoke at the event. He pointed to 2 ACA committees that might have major impacts on the way reform is implemented.
According to Elhauge, the Center for Medicaid & Medicare Innovation and the Independent Medicare Advisory Board may increasingly regulate firms’ interactions with physicians and assign a value to each treatment or procedure. Elhuage favors giving employers the ability attract enrollees with a separate risk-adjusted payment that must be spent on care for the entire group.

Elhauge also voiced his concern that there were not enough incentives for Accountable Care Organizations to coordinate.

"Preemption power of the broad sort is like CMI and IMAB; that’s where I see the ultimate promise, rather than in the ACO organizations," he explained.

Other panelists at the Health Law in Review discussion included Glenn Cohen (assistant professor at Harvard Law School and co-director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School); Holly Fernandez Lynch (executive director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics); Wendy Parmet (associate dean at Northeastern University School of Law); Renee Landers (law professor at Suffolk University Law School); Aaron Kesselheim (research associate, Dept. of Health Policy & Management, Harvard School of Public Health); and Kevin Outterson (Boston University associate professor of health law, bioethics and human rights). The event was held Feb. 1, 2013 at Harvard Law School.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply